作者:Timothy S Powers、William D Wulff、John Quinn、Yan Shi、Weiqin Jiang、Richard Hsung、Mark Parisi、Annette Rahm、Xiao Wu Jiang、Glenn P.A Yap、Arnold L Rheingold
DOI:10.1016/s0022-328x(00)00734-8
日期:2001.1
these complexes. The imidazolidinone complexes are best prepared by adding an imidazolidinone or lithiated imidazolidinone to a methoxy carbene complex or to an in-situ generated acetoxy carbene complex. α,β-Unsaturated imidazolidinone complexes are prepared by aldol condensations of alkyl imidazolidinone complexes or by alkylaltion of these complexes with bromomethyl methyl ether and then elimination
(CO)4 M = CC(R 1)NCO(CHR 2 CHR 3 X)类型的几种内部螯合的咪唑啉酮和恶唑烷酮费希尔卡宾配合物的合成据报道,其中M =铬,钨;[R 1 =甲基,乙基,异丙基,苯基,反式-丙烯基,异丙烯基,异丁烯基,环己烯基和1-丙炔基; R 2= H,Ph,Bn,Me,Cy;R 3= H,我,Ph;X = O,NMe。四种不同的方法用于合成这些配合物。最好将咪唑烷酮或锂化的咪唑烷酮加入甲氧基卡宾配合物或原位生成的乙酰氧基卡宾配合物中来制备咪唑烷酮配合物。α,β-不饱和咪唑烷酮配合物是通过烷基咪唑烷酮配合物的羟醛缩合或通过将这些配合物与溴代甲基甲醚烷基化,然后除去甲醇而制备的。最佳的恶唑烷酮配合物是通过两步程序制备的,该过程包括向甲氧基或乙酰氧基配合物中添加β-氨基醇,然后用光气将所得的氨基卡宾配合物封闭到恶唑烷酮配合物中。